1. Home
  2. FOR vs GPCR Comparison

FOR vs GPCR Comparison

Compare FOR & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forestar Group Inc

FOR

Forestar Group Inc

HOLD

Current Price

$24.63

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$68.84

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOR
GPCR
Founded
2005
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2007
2023

Fundamental Metrics

Financial Performance
Metric
FOR
GPCR
Price
$24.63
$68.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
11
Target Price
$31.25
$97.90
AVG Volume (30 Days)
141.1K
2.4M
Earning Date
01-20-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.29
N/A
Revenue
$1,662,400,000.00
N/A
Revenue This Year
$0.58
N/A
Revenue Next Year
$8.73
N/A
P/E Ratio
$7.49
N/A
Revenue Growth
10.14
N/A
52 Week Low
$18.00
$13.22
52 Week High
$29.44
$94.90

Technical Indicators

Market Signals
Indicator
FOR
GPCR
Relative Strength Index (RSI) 43.15 67.64
Support Level $24.25 $66.58
Resistance Level $24.67 $72.00
Average True Range (ATR) 0.71 3.84
MACD -0.18 -0.34
Stochastic Oscillator 17.26 75.13

Price Performance

Historical Comparison
FOR
GPCR

About FOR Forestar Group Inc

Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. the company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: